Carvykti
(ciltacabtagene autoleucel)CARVYKTI 100,000,000 CELLS in 30 ML InjectionCARVYKTI 100,000,000 CELLS in 70 ML Injection
Dosage & administration
For autologous use only. For intravenous use only.
biomarker testing
Carvykti clinical details
Genetic testing requirements were obtained from the NCCN guidelines for each cancer type. drug label
Carvykti prescribing information
prior authorization
Carvykti prior authorization resources
patient education
Carvykti patient education
Getting started on Carvykti
To share resource; ask patient to: 1.Pull out phone
2.Open camera
3.Scan QR code with camera
Other resources
Learn MoreOther resources brands publish to help support patients.
people also ask
Carvykti FAQs
How is the dosage of Carvykti?Carvykti is available in 2 dosages, including 1,430,000 cells/ml Injection 70 ml and 3,330,000 cells/ml Injection 30 ml
What does Carvykti treat?Carvykti treats Multiple Myeloma
How Is Carvykti Administered?Carvykti is administered as a Injectable
We receive information directly from the FDA and PrescriberPoint is updated as frequently as change are made available